Analysis of relationships between structure and activity of beta _3-adrenoceptor agonists and antagonists by molecular modeling
Analysis of relationships between structure and activity of beta _3-adrenoceptor agonists and antagonists by molecular modeling
批准号:
08670127
负责人:
NAGATOMO Takafumi
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
(目的)本研究的目的是研究(1)评价几种激动剂和拮抗剂对大鼠白色脂肪组织(WAT) β _3-肾上腺素能受体(β _3-AR)的亲和力;(2)通过分子模型研究β _3-AR激动剂和拮抗剂的结构和活性之间的关系。实验方法采用放射配体结合实验和分子模拟。(结果与讨论)(1)高亲和力结合位点(beta_2-AR)和低亲和力结合位点(beta_3-AR)在WAT中共存。(2)获得了选择性β - 3- ar激动剂(BRL37344A、BRL35135A、SR59230A)对WAT β - 3- ar的高亲和力。另一方面,心得洛尔和博品多洛尔对该亚型的亲和力也较低。(3)通过建模,bopindolol和心得安可能的结合位点与假设的β 3- ars的3、4、5和6螺旋有关。氨基、苯甲酸和吲哚甲基官能团可能分别与Asp117(螺旋3)、Ser169(螺旋4)和Ala311(螺旋6)相互作用。bopindolol的t-丁基可与Val116(螺旋3)、Pro307(螺旋6)和Cys304(螺旋6)残基相互作用,苯基可与Val217和Pro216(螺旋5)相互作用。此外,吲哚环可能与Trp113(螺旋3)和Phe308(螺旋6)残基相互作用。对比心得洛尔的萘基团和吲哚多洛尔的吲哚甲基,定性观察到萘基团比吲哚多洛尔的吲哚甲基在β - 3- ar中的相互作用少,尽管萘和吲哚基团的结合机制几乎相同。在β 2- ar中,bopindolol的吲哚基团与Val292存在相互作用,而心得安的萘基团与Val292没有相互作用。相反,bopindolol的t-丁基和心得安的异丙基的相互作用被假设发生在受体的相同残基上。在β - 3- ar中,不同的氨基酸对配体与β - 3- ar的相互作用也有影响。少
英文摘要
(Object)The object of this study was to examine (1)evaluation of several agonists antagonists for affinities to beta _3-adrenoceptor (beta _3-AR) in rat white adipose tissues (WAT) and (2)relationships between structure and activity of beta_3-ARs agonists and antagonists by molecular modeling. The method for these experiments were used the radioligand binding assay and the molecular modeling. (Results and Discussion) (1)high affinity binding sites (beta_2-AR) and low affinity binding sites (beta_3-AR) coexisted in WAT.(2) High affinity of selective beta_3-AR agonists (BRL37344A,BRL35135A,SR59230A) to beta_3-AR in WAT were obtained. On the other hand, low affinity of propranolol and bopindolol to this subtype was also obtained. (3) Through modeling, possible binding sites for bopindolol and propranolol involved the 3,4,5 and 6 helices of the beta_3-ARs as hypothesized. Amino, benzoic, and indole methyl functional groups possibly interacted with the Asp117 (helix 3), Ser169 (helix 4), an … More d Ala311 (helix6), respectively. The t-butyl group of bopindolol could interact with the Val116 (helix 3), Pro307 (helix6) and Cys304 (helix 6) residues and the phenyl group could interact with the Val217 and Pro216 (helix5). In addition, the indole ring possibly interacted with the Trp113 (helix 3) and Phe308 (helix 6) residues. In a comparison between the naphthalene group of propranolol and the indole methyl group of bopindolol, less interaction of naphthalene group was qualitatively observed than that of indole methyl group of bopindolol In the beta_3-AR,although the mechanism of binding of both of naphthalene and indole group binding is almost same. While there is interaction of the indole group of bopindolol to Val292 in the beta_2-AR,no interaction by the napthalene group of propranolol to Val292 was observed. Conversely, interactions of the t-butyl group of bopindolol and isopropyl group of propranolol were hypothesized to occur at the same residues in the receptor. In beta_3-AR,different amino acids also affected on the interaction between ligands and beta_3-ARs. Less
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kubo, S., et al.: "Assessment of beta_2-and beta _3-Adrenoceptors in Rat white Adipose Tissue by Radioligand Binding Assay." Biol.Pharm.Bull. 20(February). 142-148 (1997)
Kubo, S., 等人:“通过放射性配体结合测定评估大鼠白色脂肪组织中的 β_2-和 β_3-肾上腺素受体。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kubo et al.: "Assessment of β_2- and β_3- Adrenoceptors in Rat White Adipose Tssues by Radioligand Binding Assay" Biological & Pharmaceutical Bulletin. 20(2). 142-148 (1997)
Kubo 等人:“通过放射性配体结合测定评估大鼠白色脂肪组织中的 β_2- 和 β_3- 肾上腺素受体”《生物与制药通报》20(2) (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nagatomo, T., et al.: "Analysis of binding sites of non-selective beta-blocker, bopindolol, with beta-adrenoceptor subtypes by molecular modeling. (in Japanese)" HEART. (in press). (1998)
Nagatomo, T. 等人:“通过分子模型分析非选择性 β 受体阻滞剂波吲洛尔与 β 肾上腺素受体亚型的结合位点。(日语)”HEART。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
長友 孝文 他: "Molecular modelingによる非選択的β遮断薬ボピンドロールとβ_2-アドレナリン性受容体サブタイプとの相互作用部位の解析" 心臓. (1998)
Takafumi Nagatomo 等人:“通过分子模型分析非选择性 β 受体阻滞剂波吲洛尔与 β_2 肾上腺素受体亚型之间的相互作用位点”Cardiac (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kubo et al: "Assessment of β_2- and β_3-Adrenocceptors in Rat White Adipose Tissues by Radioligand Binding Assay" Biol.Pham.Bull.20. 142-148 (1997)
Kubo 等人:“通过放射性配体结合测定评估大鼠白色脂肪组织中的 β_2- 和 β_3-肾上腺素受体”Biol.Pham.Bull.20 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Study on the clarification of molecular and pharmacological structure-activity relationships of 5-HT2A antagonists
-
批准号:17590231
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2005
-
负责人:NAGATOMO Takafumi
-
依托单位:
Analysis of 3-dimentional structure β-adrenoceptor ligands and receptor complex by NMR
-
批准号:15590239
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:NAGATOMO Takafumi
-
依托单位:
The Role of Carbohydrate Moiety in Alpha_1-adrenoceptors in Rat Heart : Composition with those of Beta_1-adrenoceptors (1988-1989).
-
批准号:63570102
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1988
-
负责人:NAGATOMO Takafumi
-
依托单位: